Cargando…
LYECs: lysosome-enhancing compounds as potential therapeutic approaches for Alzheimer disease
More than 55 million people are suffering from Alzheimer's disease (AD), but there is still no effective treatment for it. Therefore, novel therapeutic approaches and regulatory mechanisms of protein quality control need to be further evaluated and dissected. The lysosome is one of the major de...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Taylor & Francis
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10262797/ https://www.ncbi.nlm.nih.gov/pubmed/36215390 http://dx.doi.org/10.1080/15548627.2022.2131247 |